Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

MediTrack Project - Track & Trace System for Pharmaceuticals


Announcement of Training Courses on the MediTrack System 

In implementation of Resolution No. 988/1 issued on August 21, 2023, the Ministry of Public Health is organizing training courses on the MediTrack drug tracking system for all pharmacies licensed by the Ministry of Public Health, according to the geographical distribution of these pharmacies.

The training courses will take place online via "Zoom".

Therefore, all pharmacists who own licensed pharmacies wishing to train are required to submit an application via the following url :  https://forms.gle/fhtgp5L9dBCxS1W6A

The World Health Organization will distribute the 2D Barcode Readers to all pharmacies that participated in the training.

We hope that everyone will cooperate and coordinate with the Ministry of Public Health and the e-Health Program to implement this system to control the process of dispensing medications and to ensure the safe delivery of medication to the patient.

For review and inquiries, please contact the e-Health Program via:
Email: ehealth@moph.gov.lb 
Phone: 01-830268 or 01-830292
 
 
Project Definition
Strategic Framework
 
  • This project comes within the plan to reform and develop the pharmaceutical sector in Lebanon by reviewing legislation, regulating the process of drug registration and pricing, and formulating quality assurance standards and programs with the aim of providing safe and quality-assured medicine at the right price for the patient.
  • The E-Health Program team at the Ministry of Public Health implements and manages this project under the leadership of the Program Director, Mrs. Lina Abu Mrad, and in coordination with the Pharmacy Department and its affiliated departments and the IT Department, and in cooperation with all concerned authorities and stakeholders in the health sector.
  • This project is being implemented with the support and funding of the World Health Organization, the Italian government, and the European Union, where the necessary hardware and equipment are provided, including servers, computers and barcode readers.

Project Goals and Importance
  • Ensuring safe drug access to the patient.
  • Controlling the dispensing of subsidized medicines.
  • Preventing medicines storage.
  • Visibility and Protection from the point of manufacture to sale to the consumer.
  • Production process compliant with regulations.
  • Reducing counterfeited and illegal drugs.
  • Fast recalls from the market.
  • Fast Reimbursement and fraud control at the third party payers
 
 
Project Summary
 
  • Work has begun on this project in the Ministry of Public Health since 2017, several regulatory decisions have been issued with the aim of implementing the 2D Matrix Barcode on all medicines registered or intended to be registered at the Ministry of Public Health by all pharmaceutical institutions and pharmaceutical factories duly registered in the Ministry of Public Health and which intends to manufacture or import medicines.
 
  • Barcode Structure
The two-dimensional barcode is compliant with international standards issued by the Global Standard Organization (GS1) and contains the below information:
 
AI Description Numbers
GTIN 1
Batch or Lot # 10
Expiry Date 17
The manufacturer prints the two-dimensional barcode on the outer packaging of the drug.
  • In 2017, the Ministry of Public Health developed an information system to track and trace the medicines (MediTrack) within the supply chain from manufacturing, to storage, distribution and dispensing to patients through a unified drug identification number (2D Matrix barcode).
  • The pilot phase of MediTrack began in March 2018, in which about 19 pharmaceutical institutions participated, till the end of 2018, as per the ministerial decision No. 2428 dated 12/14/2017.
  • In 2020, the Lebanese Ministry of Public Health issues guidelines, according to the international guidelines of the GS1, and stresses the importance of adhering to this manual by all parties involved, as relevant to the particular role that they play, believing that the barcoding technology adds an extra level of patient safety to the medication administration process.
  • At the end of 2020, the MediTrack system was implemented with drug warehouse owners in Lebanon, and all importers and distributors of medicines in Lebanon were connected to the information system to track the movement of imported medicines.
  • In the summer of 2022, the decrease in the budget allocated by the Central Bank of Lebanon for total subsidies for catastrophic illnesses led to an urgent need to track the dispensing of subsidized medicines up to the patient level in both the public and private sectors. The Ministry of Public Health took this opportunity to accelerate the implementation of the MediTrack system in hospitals and pharmacies as a way to control the sale of subsidized cancer medicines and to prevent the storage of medicines or their transfer to foreign markets.
  • Since August 2022, pharmaceutical institutions (hospitals, pharmacies, pharmaceutical factories, importers, distributors, security forces, donors, non-governmental organizations and health care centers...) have been trained and connected to the MediTrack system because the dispensing of some cancer drugs and other subsidized drugs must be done exclusively on the MediTrack system as per Minister Decision No. 6/1 issued on 5/1/2023.  The patient must be registered in a center identified by MoPH to have a Unique Health ID as a condition for obtaining the treatment.
  • Since the beginning of this year 2023, the national pharmaceutical manufacturers have also started working on applying and printing two-dimensional barcodes on all locally manufactured medicines. They have also been trained on MediTrack system and they started working on it. Thus, all medicines in the Lebanese markets are now tracked within the supply chain.
  • From 2017, several decisions and regulatory documents (more than 30) have been issued to keep pace with the implementation and development of this project.
  • Coordination is made on a permanent basis with the Department of Pharmacy in legislative matters, especially with regard to pharmaceutical institutions and the organization of the drugs registration and pricing process. Coordination is also made with the Pharmacy Inspection Department in terms of checking and validating the information of imported drugs and their invoices entered on MediTrack by importers in order to to approve their distribution.
  • Cooperation is also taking place with the IT Department regarding the implementation of the “Unique Health ID” platform and training of registration centers identified by MoPH to use this platform to register patients and provide them with their Unique ID in order to have access to treatment.   
 
Information Flow

 
Administrative Procedures for Patient's Access to Drugs through Meditrack
 
للحصول على الدواء
 
مريض السرطان:
  1.  الحصول على رقم صحي موحد
  2. التواصل مع طبيبك المختص لتعبئة ملف خاص بك على منصة امان
  3. انتظار رسالة نصية من وزارة الصحه تبلغ المريض اذا كان ( مقبول، مرفوض، قيد الدرس ) بحالة القبول عليه المتابعه مع المستشفى اذا كان الدواء يعطى من خلال الوريد، في حال كان الدواء يعطى على شكل حبوب / حقن سيتم التواصل مع المريض من خلال فريق عمل وزارة الصحه خلال مهلة اسبوع لمعرفة الصيدليه القريبه من السكن و ارسال الدواء اليه من ثم يتابع المريض بعدها مع الصيدليه شهريا . 
مريض التصلب اللويحي :
  1. الحصول على رقم صحي موحد
  2. التواصل مع طبيبك المختص لتعبئة ملف خاص بك على منصة امان
  3. انتظار رسالة نصية من وزارة الصحه تبلغ المريض اذا كان ( مقبول، مرفوض، قيد الدرس ) بحالة القبول عليه المتابعه مع المستشفى اذا كان الدواء يعطى من خلال الوريد، في حال كان الدواء يعطى على شكل حبوب / حقن سيتم التواصل مع المريض من خلال فريق عمل وزارة الصحه خلال مهلة اسبوع لمعرفة الصيدليه القريبه من السكن و ارسال الدواء اليه من ثم يتابع المريض بعدها مع الصيدليه شهريا. 
مريض الهيمو فيليا :
  1. الحصول على رقم صحي موحد 
  2. التواصل مع طبيبك المختص لتعبئة ملفك الصحي على  منصة امان
  3. أو تقديم المستندات التالية إلى وزارة الصحة العامة او اقرب مركز لها أو ارسالها عبر رسالة واتساب على الرقم التالي  81/348838
المستندات المطلوبه هي :
صورة عن الهوية، رقم صحي موحد، تقرير طبي مفصل  (مع ذكر الدواء والعيار والجرعة اليومية)، وصفة طبية موحدة.
تقوم الشركة بتسليم الدواء للصيدلية المحددة او عبر الكرنتينا اذا كان المريض غير مضمون او عبر مراكز الدواء الموزعه بالمراكز.
تستغرق هذه العملية تقريبا ٥ ايام عمل بدء من وقت تسليم المستندات المتعلقة بالمريض لجانب وزارة الصحة العامة

مرضى التلاسيميا :
  1.  الحصول على رقم صحي موحد 
  2. التواصل مع طبيبك المختص لتعبئة ملفك الصحي على  منصة امان
  3. أو تقديم المستندات التالية إلى وزارة الصحة العامة او اقرب مركز لها أو ارسالها عبر رسالة واتساب على الرقم التالي  81/348838
المستندات المطلوبه هي :
صورة عن الهوية، رقم صحي موحد، تقرير طبي مفصل  (مع ذكر الدواء والعيار والجرعة اليومية)، وصفة طبية موحدة.
 
مرضى الزرع: دواء Advagraf or Prograf
  1. الحصول على رقم صحي موحد 
  2. التواصل مع طبيبك المختص لتعبئة ملفك الصحي على  منصة امان
  3. او اعطاء وزارة الصحه المستندات التاليه :
 
  • تقرير طبي جديد  (تقرير طبي جديد  يقدم لمرة واحدة يبين ان المريض اجريت له عملية زراعة عضو وهو بحاجة لهذا الدواء مدى الحياة) .
  • رقم صحي موحدد
  • وصفة طبية جديدة لا تقل عن شهر  ( مع ذكر الدواء والعيار والجرعة اليومية) وارسالها عبر رسالة واتساب على الرقم التالي  81/348838.
تقوم الشركة بتسليم الدواء للصيدلية المحددة او عبر الكرنتينا اذا كان المريض غير مضمون او عبر مراكز الدواء الموزعه بالمراكز  
تستغرق هذه العملية تقريبا ٥ ايام عمل بدء من وقت تسليم المستندات المتعلقة بالمريض لجانب وزارة الصحة العامة
 
دواء من الهبة المقدمة بشكل استثنائي لفترة ثلاثة اشهر :  Humira
الحصول على رقم صحي موحد
التوجه لوزارة الصحه الطابق الرابع لاعطائها المستنداتت التاليه :
  1. رقم الصحي الموحد
  2. صورة عن الهويه
  3. تقرير طبي مفصل من الطبيب المختص (روماتيزم، جهاز هضمي، العيون و الجلديه )  
  4. وصفه طبيه موحدة ( مع ذكر اسم الدواء والجرعه المسموح فيها شهريا )
  5. فحوصات مخبريه : sgot, sgpt, creatinine, cbc
 
Guidelines for Pharmacy Stock Management Systems Integration with MediTrack System
  • API documentation that is needed by the pharmacy software companies to start the integration with MediTrack are listed below:
Patient UHID
Pharmacy Movements
Pharmacy Sales API
 
  • The test environment base URLs:
To make sure that your Pharmacy Stock Management System is compliant with MediTrack guidelines, below are the primary URLs for trials by software company owners:

Nevertheless, please be aware that we have two API services at MOPH, namely
 /api and /meditrackapi.
You can find these services at the following URLs:
1.    https://meditrack.moph.gov.lb:38440/api
2.    https://meditrack.moph.gov.lb:38440/meditrackapi
It is essential to obtain the token from the same application (same BaseURL)

Patient UHID base URL: https://meditrack.moph.gov.lb:38440/meditrackapi/
Pharmacy Movements base URL: https://meditrack.moph.gov.lb:38440/api/
Pharmacy Sales base URL: https://meditrack.moph.gov.lb:38440/
 
 
Guidelines-Implementation of the 2D BarCode on Pharmaceuticals
In order to ensure the patient’s access to safe drugs, the Ministry of Public Health has adopted the two-dimensional (2D) barcode as a unified identification number on the package of the pharmaceutical products. The 2D barcode will help trace these products within the supply chain, from manufacturing, to storage, distribution and receipt of drugs by patients.

It has therefore become necessary to develop this manual designed to ensure the adoption of the necessary standards to include the barcode on drugs and help seize smuggled and counterfeit drugs in the Lebanese market.

Guidelines-Implementation of the 2D BarCode on Pharmaceuticals-Edition2-2020 (update related to the barcode reader configuration)

Director General Letter 2020/4/15753 in 22/5/2020
 
Pharmaceutical Companies Connected to "Meditrack System"
 
Laws And Regulations
 
 
Presentations
 
Contacts Us
Phone Number:
01/830300 Ext:292- 268- 265

Emails:
ehealth@moph.gov.lb
drugsbarcode@moph.gov.lb
 
Media

    3
    ...
ATC Name B/G Ingredients Dosage Form Price
L04AX07 MAROVAREX G Dimethyl Fumarate - 240mg Capsule, hard, gastro-resistant 60,848,734 L.L
D07CA01 MYCICORT G Neomycin sulfate - 5mg/g, Hydrocortisone acetate - 10mg/g Ointment 485,063 L.L
J01CR02 MEGAMOX-JPI ES G Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml 600mg Powder for suspension 908,438 L.L
N06DA52 MEXAZIL XR 28/10 G Memantine HCl - 28mg, Donepezil HCl - 10mg Capsule 4,333,444 L.L
J01GB06 MIACIN G Amikacin (sulfate) - 500mg/2ml 500mg/2ml Injectable solution 2,015,764 L.L
N06DA52 MEXAZIL XR 14/10 G Memantine HCl - 14mg, Donepezil HCl - 10mg Capsule 3,432,174 L.L
N06DX01 MEMANTINE ARROW LAB G Memantine HCl - 10mg 10mg Tablet, film coated, scored 1,404,315 L.L
N06DX01 MEMANTINE BIOGARAN G Memantine HCl - 10mg 10mg Tablet, coated, scored 2,444,450 L.L
M05BA04 MARVIL 70 G Alendronate (monosodium trihydrate) - 70mg 70mg Tablet, coated 1,173,175 L.L
N05AN01 MANICARB SR-400 G Lithium carbonate - 400mg 400mg Tablet, prolonged release 1,431,192 L.L
N06DX01 MEMORA G Memantine HCl - 10mg 10mg Tablet, film coated 849,820 L.L
J01CR02 MEGAMOX-JPI G Amoxicillin (trihydrate) - 500mg, Clavulanic Acid (potassium) - 125mg 625mg Tablet 245,923 L.L
N06DX01 MEMANTINE ARROW LAB G Memantine HCl - 20mg 20mg Tablet, film coated 1,342,499 L.L
N06DX01 MEMANTINE BIOGARAN G Memantine HCl - 20mg 20mg Tablet, coated 2,444,450 L.L
R05CA03 MUCINEX G Guaifenesin - 600mg 600mg Tablet, extended release 749,864 L.L
N06DX01 MEMORA G Memantine HCl - 20mg 20mg Tablet, film coated 1,593,413 L.L
N07AA01 METHYL SULFATE DE NEOSTIGMINE RENAUDIN G Neostigmine methyl sulfate - 0.5mg/ml 0.5mg/ml Injectable solution 467,657 L.L
J01CR02 MEGAMOX-JPI G Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg 1g Tablet 338,648 L.L
J01CR02 MOXICLAV G Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg 1g Tablet 349,399 L.L
L01EB02 MIRATA G Erlotinib (HCl) - 100mg 100mg Tablet, film coated 77,485,888 L.L
M05BA07 MADRONATE G Risedronate sodium - 35mg 35mg Tablet, film coated 724,907 L.L
L01EB02 MIRATA G Erlotinib (HCl) - 150mg 150mg Tablet, film coated 88,722,301 L.L
D08AK04 MERCUROCHROME A TIGE G Mercuresceine sodium - 2% 2% Solution 119,026 L.L
R05CB03 MUCOTAL PEDIATRIQUE G Carbocysteine - 100mg/5ml 100mg/5ml Syrup 298,205 L.L
S03CA04 MYCICORT G Hydrocortisone acetate - 5mg, Neomycin sulfate - 5mg Drops suspension 166,381 L.L
J07AH MENFIVE G Meningococcal (serogroups A, C, Y, W, X) Polysaccharide conjugate vaccine - Injectable freeze dried powder + diluent 3,527,587 L.L
R05CB03 MUCOTAL ADULTE G Carbocysteine - 250mg/5ml 250mg/5ml Syrup 308,444 L.L
J07AH08 MENQUADFI G Meningococcal (serogroups A, C, W and Y) conjugate vaccine - Injectable solution 4,859,334 L.L
R05CB06 MUCUM G Ambroxol HCl - 15mg/5ml 15mg/5ml Syrup, sugar free, alcohol free 98,101 L.L
A11CC05 MAXI-D 10.000 G Vitamin D3 - 10,000IU 10,000IU Capsule 895,895 L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2024